Synbiosis

Cambridge, United Kingdom Founded: 1985 • Age: 41 yrs
Automated colony counting and zone sizing for the microbiology laboratory

About Synbiosis

Synbiosis is a Healthcare company based in Cambridge (United Kingdom) founded in 1985. Automated colony counting and zone sizing for the microbiology laboratory. The company has 21 employees. Its chief executive, as recorded, is Brian Stammers. Synbiosis offers products and services including AutoCOL, ProtoCOL 3, and ProcScan. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its legal entity is SYNOPTICS LIMITED. Its competitors include Oxford Instruments and Chromacity; 1 of its 2 listed competitors has raised funding.

Company details

Synbiosis, a division of the Synoptics group is engaged in manufacturing and marketing of automated systems for rapid, accurate colony counting and inhibition zone measurement. Its product line includes ChromaZona an IVD instrument for automated antibiotic susceptibility testing and microbial ID in the clinical laboratory, ProtoCOL 3 , the next generation instrument for colony counting, zone measurements, (inhibition and AST), membranes, Protos 3 an automated colony counter and chromogenic identification system for use in food and environmental microbiology laboratories, ProDilute, gravimetric diluter and ProBlend a paddle blender for use in the microbiology laboratory.for use in the microbiology laboratory. The company markets its products through an international network of over 90 highly-trained distributors.

  • Headquarters Cambridge, United Kingdom
  • Employees 21
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website synbiosis.com
  • Social LinkedIn X Facebook
  • Legal Name Synoptics Limited
  • Date of Incorporation 31 Dec, 1984
  • Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE
Key Metrics
  • Annual Revenue
    $6.48 M (USD)
    as on Apr 30, 2016
  • Net Profit
    -$154.79 K (USD)
    65
    as on Apr 30, 2016
  • EBITDA
    -$326.54 K (USD)
    26
    as on Apr 30, 2016
  • Employee Count
    21

Products & Services of Synbiosis

Synbiosis offers a comprehensive portfolio of products and services, including AutoCOL, ProtoCOL 3, and ProcScan.

AutoCOL
Colony Counter

Automated system for counting microbial colonies in labs.

ProtoCOL 3
Zone Measuring System

Device for precise inhibition zone measurement in microbiology.

ProcScan
Analysis Software

Tool for antibiotic sensitivity testing and data analysis.

People of Synbiosis

1 people are tracked at Synbiosis (1 in leadership); the tracked headcount is 21.

NameRoleGroup
Brian Stammers
CEOLeadership
Premium access

Complete people profiles for Synbiosis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Synbiosis

Synbiosis has 2 listed competitors in our database, 1 of them funded. They include Oxford Instruments and Chromacity.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
oxinst.com1959Abingdon, United Kingdom2,027
Technology tools and systems for molecular scale are developed.
chromacitylasers.com2013Edinburgh, United Kingdom$4.93M12
Tunable fiber lasers are provided for industrial and scientific applications.
Premium access

Detailed competitors of Synbiosis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Synbiosis

Websites that share an audience with Synbiosis (synbiosis.com).

Similar websites

Websites whose visitors overlap most with Synbiosis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
syngene.com
syngene.com
100%
–
colony-counter.com
96%
View details
bioras.com
bioras.com
96%
–
biocompare.com
91%
244.1K#187,636View details
edwardsco.com.au
75%
#5,640,891View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 11 similar websites and full traffic analytics for Synbiosis

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Synbiosis (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Synbiosis

Premium access

Complete news archive for Synbiosis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Synbiosis

Synbiosis was founded in 1985.

Synbiosis is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Brian Stammers is the CEO of Synbiosis, as recorded in our data.

Synbiosis has 21 employees.

Annual revenue of Synbiosis is $6.48M as on Apr 30, 2016.

Synbiosis, a division of the Synoptics group is engaged in manufacturing and marketing of automated systems for rapid, accurate colony counting and inhibition zone measurement. Its product line includes ChromaZona an IVD instrument for automated antibiotic susceptibility testing and microbial ID in the clinical laboratory, ProtoCOL 3 , the next generation instrument for colony counting, zone measurements, (inhibition and AST), membranes, Protos 3 an automated colony counter and chromogenic identification system for use in food and environmental microbiology laboratories, ProDilute, gravimetric diluter and ProBlend a paddle blender for use in the microbiology laboratory.for use in the microbiology laboratory. The company markets its products through an international network of over 90 highly-trained distributors.

Synbiosis's top competitors include Oxford Instruments and Chromacity.

Synbiosis offers AutoCOL, ProtoCOL 3, and ProcScan.

Synbiosis operates through Synoptics Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available